]>
IRCT20190929044919N1 IRCT 2020-06-16 Alborz University of Medical Sciences Evaluation of adenosine efficacy in the treatment of ventricular tachycardia Comparison of the Effectiveness of 6 mg and 12 mg Adenosine in the Treatment of Paroxysmal Supraventricular Tachycardia 2019-03-20 anticipated 142 Complete https://irct.ir/trial/43396 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block randomization: In this method, four-letter cards are prepared using A-B letters and one card is selected for each patient. If the first letter is card A, the person will be in group one and if it is B, the person will be in group 2, Blinding description: In this study, while obtaining conscious consent from the patient or their companions, the participants in the intervention are unaware that they are in the intervention group one or two.In this way, the study participant is unaware of which group is involved and receives the initial dose of 12 mg or 6 mg Adenosine. 3 Paroxysmal Supraventricular tachycardia. Intervention 1: Intervention group 1: a dose of 6 mg of adenosine is used, and in case of non-response, a dose of 12 mg, and again, in case of non-response, a dose of 12 mg is used along with Valsalva maneuver. Intervention 2: Intervention group 2: Treatment is initially started with a dose of 12 mg of adenosine, and if the dose is not met, a dose of 12 mg and a valsalva maneuver will be performed. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Maryam Fadaeidashti
Shahid Rajaei Hospital,Shahid Rajaei Ave,Hesarak
Karaj Iran (Islamic Republic of) 3197635141 026334570030 fadaeedashti@abzums.ac.ir Shahid Rajaei Hospital scientific Maryam Fadaeidashti
Shahid Rajaei Hospital,Shahid Rajaei Ave,Hesarak
Karaj Iran (Islamic Republic of) 3197635141 026334570030 fadaeedashti@abzums.ac.ir Shahid Rajaei Hospital Iran (Islamic Republic of) The patient should have informed consent to participate in the study The patient has a Paroxysmal Supraventricular Tachycardia The patient's age is in the range of 70-18 years 18 years 70 years Both The Patient dissatisfaction to participate in the intervention Patient sensitivity to adenosine The patient has first and second degree AV node blocks The patient has sick sinus syndrome The patient has a history of previous seizures and epilepsy R00 Abnormalities of heart beat Treatment - Drugs Treatment - Drugs Intervention group 1: a dose of 6 mg of adenosine is used, and in case of non-response, a dose of 12 mg, and again, in case of non-response, a dose of 12 mg is used along with Valsalva maneuver Intervention group 2: Treatment is initially started with a dose of 12 mg of adenosine, and if the dose is not met, a dose of 12 mg and a valsalva maneuver will be performed Heart rhythm. Timepoint: After injecting the final dose of adenosine. Method of measurement: ECG. Alborz University of Medical Sciences Approved 2019-02-18 Ethics committee of Alborz University of Medical Sciences Safarian Alley,Golshahr,Deputy of research and technology Karaj Alborz Iran (Islamic Republic of)